Literature DB >> 8709625

BCR/ABL and leukemia.

A Butturini1, R B Arlinghaus, R P Gale.   

Abstract

This review focuses on the role of the chimeric BCR/ABL gene in leukemia development. First, we discuss and update knowledge regarding the molecular biology of BCR/ABL. We then review data regarding transforming activity of BCR/ABL. Third, we discuss the complex interactions between BCR/ABL and leukemia phenotype. We conclude with a brief discussion of possible therapeutic implications of these data.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709625     DOI: 10.1016/0145-2126(95)00057-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia.

Authors:  Hui Liu; Juan Long; Peng-Hui Zhang; Kang Li; Jun-Jie Tan; Bin Sun; Jie Yu; Zhi-Guang Tu; Lin Zou
Journal:  Int J Hematol       Date:  2011-04-12       Impact factor: 2.490

2.  Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy.

Authors:  E M Weissinger; K Oettrich; C Evans; H-G Genieser; F Schwede; M Dangers; E Dammann; H-J Kolb; H Mischak; A Ganser; W Kolch
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.